A prospective trial of CT-guided percutaneous microwave ablation for lung tumors.

ABSTRACT:

Background

Percutaneous ablation is an alternative treatment for lung cancer in non-operable patients. This is a prospective clinical trial for percutaneous microwave ablation (pMWA) of biopsy-proven lung cancer to demonstrate safety and efficacy.

Methods

A prospective trial from 6-1-2016 to 1-1-2019 enrolled patients with biopsy-proven primary or metastatic lung cancer <3 cm in size and 1 cm away from the pleura for pMWA with the Emprint Ablation System with Thermosphere Technology for Phase I analysis, (Clinicaltrials.gov; #NCT0267302). Patients were followed for 1 year with PET/CT and PET/MR to determine patterns of recurrence and efficacy of ablation.

Results

After 12 patients consented for biopsy, 6 patients underwent treatment of 7 lesions, 3/6 women, median age

SUBMITTER: Reisenauer JS 

PROVIDER: S-EPMC9096293 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature